ATHE

Alterity Therapeutics Ltd is a biopharmaceutical company based in Melbourne, Australia, specializing in the development of innovative therapies for Parkinson's disease and other neurodegenerative disorders. The company focuses on addressing significant unmet medical needs through its proprietary drug candidates and cutting-edge research programs. Committed to scientific excellence and collaborative approaches, Alterity strives to enhance patients' quality of life while advancing the field of neurological care. With a robust pipeline of potential therapeutics, the company positions itself at the forefront of addressing critical challenges in neurodegenerative disease treatment.